{"id":557,"date":"2021-05-11T18:49:40","date_gmt":"2021-05-11T09:49:40","guid":{"rendered":"https:\/\/www.ssri.com\/china\/e\/medicalnews\/?p=557"},"modified":"2021-06-07T18:50:09","modified_gmt":"2021-06-07T09:50:09","slug":"anti-cancer-drugs-more-accessible-for-clinical-use-in-china","status":"publish","type":"post","link":"https:\/\/www.ssri.com\/china\/e\/medicalnews\/557\/","title":{"rendered":"Anti-cancer drugs more accessible for clinical use in China"},"content":{"rendered":"<p>Hospitals in China saw a 15% increase in 2020 in the variety of medical insurance covered anti-cancer drugs with negotiated price cuts compared with 2019. The data was based on results from a monitoring network that covers more than 1,400 hospitals across China, Guo Yanhong, an official with the National Health Commission, told a press conference on May 10. <\/p>\n<p>In 2018, 17 anti-cancer drugs were included in China's medical insurance reimbursement list, with their prices cut by 56.7 percent on average after a round of price negotiations between the National Healthcare Security Administration and pharmaceutical companies. The hospitals under the monitoring network purchased 450.8 percent more of the 17 anti-cancer drugs on average in 2020 than in 2018, Guo said, adding that the accessibility of anti-cancer drugs for clinical use has increased. (Source: Xinhua)<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Hospitals in China saw a 15% increase in 2020 in the variety of medical insurance covered anti-cancer drugs with negotiated price cuts compared with 2019. The data was based on results from a monitoring network that covers more than 1,400 hospitals across China, Guo Yanhong, an official with the National Health Commission, told a press conference on May 10. In 2018, 17 anti-cancer drugs were included in China's medical insurance reimbursement list, with their prices cut by 56.7 percent on average after a round of price negotiations between the National Healthcare Security Administration and pharmaceutical companies. The hospitals under the monitoring network purchased 450.8 percent more of the 17 anti-cancer...  <a class=\"excerpt-read-more\" href=\"https:\/\/www.ssri.com\/china\/e\/medicalnews\/557\/\" title=\"Read Anti-cancer drugs more accessible for clinical use in China\">Read more &raquo;<\/a><\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-557","post","type-post","status-publish","format-standard","hentry","category-medicalnews"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.ssri.com\/china\/e\/medicalnews\/wp-json\/wp\/v2\/posts\/557","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ssri.com\/china\/e\/medicalnews\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ssri.com\/china\/e\/medicalnews\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ssri.com\/china\/e\/medicalnews\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ssri.com\/china\/e\/medicalnews\/wp-json\/wp\/v2\/comments?post=557"}],"version-history":[{"count":1,"href":"https:\/\/www.ssri.com\/china\/e\/medicalnews\/wp-json\/wp\/v2\/posts\/557\/revisions"}],"predecessor-version":[{"id":558,"href":"https:\/\/www.ssri.com\/china\/e\/medicalnews\/wp-json\/wp\/v2\/posts\/557\/revisions\/558"}],"wp:attachment":[{"href":"https:\/\/www.ssri.com\/china\/e\/medicalnews\/wp-json\/wp\/v2\/media?parent=557"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ssri.com\/china\/e\/medicalnews\/wp-json\/wp\/v2\/categories?post=557"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ssri.com\/china\/e\/medicalnews\/wp-json\/wp\/v2\/tags?post=557"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}